semaglutide and tirzepatide. Maintenance therapy on or tirzepatide Why You Might Tolerate One

While sulfur burps can be an uncomfortable side effect of Ozempic or other GLP-1 medications, they are usually temporary and manageable

In fact, with the exception of the lowest treatment dose investigated (2.5 mg oral semaglutide), almost 100% of patients experienced a reduction in HbA 1c in the phase II trial, indicating that the variability in semaglutide exposure is not likely to affect the proportion of subjects with a clinically relevant treatment response [10]

Cascone T, Sepesi B, Lin HY, Kalhor N, Parra ER, Jiang M, Godoy MCB, Zhang J, Fossella FV, Tsao AS, Lam VK, Lu C, Mott FE, Simon GR, Antonoff MB, Mehran RJ, Rice DC, Behrens C, Weissferdt A, Moran C, Vaporciyan AA, Lee JJ, Swisher SG , Gibbons DL, Wistuba II, William WN Jr, Heymach JV

Retatrutide Regulatory Status in Canada Investigational Drug Status Retatrutide is not an authorized health product in Canada and does not carry a Drug Identification Number (DIN), Natural Product Number (NPN), or Homeopathic Drug Number (DIN-HM) issued by Health Canada